好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A deep learning-based approach for simultaneously segmenting T2 lesions and T1 hypointensities in multiple sclerosis regulatory clinical trials
Multiple Sclerosis
MS and CNS Inflammatory Disease Posters (7:00 AM-5:00 PM)
145
To develop a convolutional neural network-based approach to simultaneously segment T2 lesions and T1 hypointensities from standard MRI sequences acquired in a regulatory clinical trial setting.
The segmentation of T2 lesions and T1 hypointensities (i.e. black holes) is a standard part of regulatory clinical trials in multiple sclerosis. Several automated approaches, including deep learning-based methods, have been proposed to facilitate such analyses. However, such tools are typically developed with ad-hoc approaches, without adequate calibration, and not incorporating regulatory environment type of quality management of the data and analyses. 

2D FLAIR, 2D T1-weighted spin echo, 2D T2-weighted spin echo, and 2D PD-weighted images were collected from 455 MRI exams coming from 63 different scanners. Gold standard T2 lesion and T1 hypointensity masks were generated by two well-calibrated MD neuroimagers and reviewed by a senior MD neuroimager. A semantic segmentation network, SegResNet, was trained using all four image types and lesion masks as input with the goal of learning to simultaneously segment T2 lesions and T1 hypointensities without any user input. The trained network was evaluated on 75 additional MRI exams and resulting segmentations were compared to gold standard masks in terms of volumetric correlation and spatial overlap (Dice similarity coefficient).

Median (interquartile range) of the gold standard T2 lesion and T1 hypointensity volumes were 14.7 (5.7 – 29.8) and 3.2 (1.3 – 9.1) mL, respectively. Automatically segmented T2 lesion volume correlated with the corresponding gold standard volume at r=0.979, p <0.001 with an average Dice value of 0.69. Automatically segmented T1 hypointensity volume correlated with the corresponding gold standard volume at r=0.968, p<0.001, with an average Dice value of 0.55. Segmentation took on average 2 seconds per case.

Deep learning-based approach rapidly yields comparable results to those obtained by calibrated expert analysts in regulatory clinical trials.
Authors/Disclosures
Niels Bergsland (Buffalo Neuroimaging Analysis Center / State University of New York At Buffalo)
PRESENTER
Prof. Bergsland has nothing to disclose.
Dejan Jakimovski, MD, PhD (Buffalo Neuroimaging Analysis Center, University at Buffalo) Dr. Jakimovski has nothing to disclose.
No disclosure on file
Robert Zivadinov, MD, PhD, FAAN (Buffalo Neuroimaging Analysis Center) The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Michael G. Dwyer III, MD, PhD (Buffalo Neurological Analysis Center) Dr. Dwyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Keystone Heart, Ltd. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Dwyer has received research support from Novartis. The institution of Dr. Dwyer has received research support from Keystone Heart, Ltd. The institution of Dr. Dwyer has received research support from Bristol Myers Squibb. The institution of Dr. Dwyer has received research support from Roche.